Scientists lead Nigeria

With a chemist and zoologist running the country, will local science reap any benefits?

Written byStephen Pincock
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
Nigerian researchers are optimistic this week that science funding and infrastructure will improve after two former scientists were elected to lead the country."We are hopeful," said Oyekanmi Nash, program director of the West African Biotechnology Worshops Series, based at the University of Ibadan in Nigeria. "We are happy that for the first time in Nigeria's history we have a president and vice president who are both scientists." Last week, President Umar Musa Yar'Adua, a chemistry graduate, and Vice President Goodluck Jonathan, who holds a PhD in zoology, took office after elections that were peaceful but clouded by accusations of corruption.Nigerian science has already made significant gains over the past eight years under the presidency of Olusegun Obasanjo, Nash said. "Even before this election, the previous government had been re-awakening funding to science and technology. We hope that [the new leaders] will advance that work." For example, in 2004, the Nigerian science minister Turner Isoun told the newsletter of the Third World Academy of Sciences that the national government's budget for scientific research rose from about 1.5 billion Nigerian Naira (NGN) in 1998 (about US$11.5 million at 2004 exchange rates) to 5 billion NGN (over US$38 million) in 2004. The Economist estimates the Nigerian gross domestic product in 2006 to be US$116 billion. Oliver Ezechi, chief research fellow at the Nigerian Institute of Medical Research in Lagos, agreed that continued expansion was important. "What we hope is that they will build on what has already been put in place in the past," he told The Scientist.But John Mugabe, science advisor to the New African Partnership for Economic Development, based in South Africa, was somewhat less optimistic about Yar'Adua's immediate impact on research. "Nigeria is lucky to have a scientist as president," he said, "but progress depends on a number of other factors."Without the support of the parliament, state governors, and the Nigerian people, Yar'Adua and Jonathan will have a hard time building science capacity, Mugabe said. "The challenge for the president and Nigerian scientists is to build a public constituency for science," he told The Scientist. "The legislature and political parties must be champions for science, technology and innovation, otherwise nothing will change."For Nigerian scientists, even basic improvements would help. One immediate priority for the new leaders should be to stabilize power supplies, Nash said. "The current [unstable] supply (and the attendant cost for back-up generators) is not good enough for scientific research and development, including industrialization," he said in an Email. "Fortunately, the president has put the subject as a national emergency." Beyond that, it would be nice to see an initial focus on infrastructure and equipment for research, Ezechi added. "We have a lot of scientists who are trained," but can't work due to lack of facilities, he said. Nigeria's public universities have been closed since late March, due to an ongoing strike by lecturers demanding improved working conditions.More immediately, Nigeria's new leaders will be dealing with a host of other problems, including attacks on oil facilities in the Niger delta, and a dispute with drug firm Pfizer over the deaths of children given meningitis drugs during a trial in 1996. The Nigerian state of Kano, where the deaths occurred, has brought criminal charges against the company, as has the federal attorney general's office. The suits center on claims the company secretly imported an untested drug and tested it on vulnerable Nigerian citizens. Pfizer has denied the claims and said it conducted the trial in an ethical manner.Ezechi said he wasn't sure the courts were the right place to address the dispute with Pfizer. "I would prefer a government-mediated resolution," he said. "Going to court can drag on for several years."Stephen Pincock mail@the-scientist.comLinks within this articleS. Pincock, "The long journey home," The Scientist, June 1, 2006. http://www.the-scientist.com/article/display/23579Oyekanmi Nash http://www.aecom.yu.edu/prasadlab/people.htmlS. Babalola, "In with the new: Nigeria's 'science' president," SciDev.net, May 29, 2007. 'http://www.scidev.net/gateways/index.cfm?fuseaction=readitem&rgwid=4&item=Features&itemid=609&language=1"Science in Nigeria," TWAS newsletter, 2004. 'http://www.ictp.trieste.it/~twas/pdf/NL16_3-4_PDF/10-Isoun_49-52_lo.pdfThe Economist Country Briefings: Nigeria http://www.aecom.yu.edu/prasadlab/people.htmlOliver Ezechi http://www.the-scientist.com/supplementary/html/53268/1.htmlJ. Mugabe, "Moving African science forward," The Scientist, January 2006. http://www.the-scientist.com/article/display/23584/E. Edukugho, "Nigeria: Obasanjo dares ASUU says, no-work-no-pay," Vanguard, May 24, 2007 http://allafrica.com/stories/200705240176.htmlJ. Stephens, "Pfizer faces new charges over Nigerian drug test," Washington Post, June 2, 2007. http://www.washingtonpost.com/wp-dyn/content/article/2007/06/01/AR2007060102197.html
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform